Sign in

CIK 0000025743

  • Non-accelerated filer
  • Smaller reporting company

TherapeuticsMD, Inc.

Sign in to watch
Ticker
TXMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
870233535
Phone
+1 561-961-1900
Business address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
Former names
AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-11-03 Collins Cooper C. Director Grant or award · Restricted Stock Units +8,500 8,500
2025-02-18 Collins Cooper C. Director Exercise or conversion +8,500 60,516
2025-02-18 Collins Cooper C. Director Exercise or conversion · Restricted Stock Units −8,500 0
2024-08-22 Collins Cooper C. Director Purchase +4,094 $1.73 $7K 52,016
2024-08-21 Collins Cooper C. Director Purchase +1,200 $1.70 $2K 47,922
2023-07-17 Collins Cooper C. Director Grant or award · Restricted Stock Units +8,500 8,500
2022-09-29 Collins Cooper C. Director Grant or award · Restricted Stock Units +5,000 5,000
2022-08-18 Collins Cooper C. Director Exercise or conversion +1,984 46,722
2022-08-18 Collins Cooper C. Director Exercise or conversion · Restricted Stock Units −1,984 0
2021-11-18 Collins Cooper C. Director Purchase +1,000,000 $0.58 $579K 2,236,864
2021-08-18 Collins Cooper C. Director Purchase +900,000 $0.72 $648K 1,236,864
2021-08-17 Collins Cooper C. Director Purchase +100,000 $0.77 $77K 336,864
2021-08-10 Collins Cooper C. Director Exercise or conversion +96,864 236,864
2021-08-10 Collins Cooper C. Director Exercise or conversion · Restricted Stock Units −96,864 0
2021-07-01 Collins Cooper C. Director Grant or award · Restricted Stock Units +99,174 99,174
2020-06-18 Collins Cooper C. Director Grant or award · Restricted Stock Units +96,864 96,864
2020-06-09 Collins Cooper C. Director Purchase +47,500 $1.45 $69K 140,000
2020-06-08 Collins Cooper C. Director Purchase +26,500 $1.45 $38K 92,500
2019-06-20 Collins Cooper C. Director Grant or award · Non-Qualified Stock Option (right to buy) +75,000 75,000
2019-05-13 Collins Cooper C. Director Purchase +30,000 $3.33 $100K 66,000

Page 1 of 2 · 21 trades